MedPath

A randomised trial of hepatitis B booster vaccination at the age of 13 to 15 years following infant vaccination to assess efficacy against hepatitis B infection and acute hepatitis

Completed
Conditions
Hepatitis B Virus
Infections and Infestations
Hepatitis B
Registration Number
ISRCTN71271385
Lead Sponsor
Medical Research Council (MRC) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
500
Inclusion Criteria

Added as of 23/04/2007:
1. ID and vaccination data matched with Gambia Hepatitis Intervention Study (GHIS) database
2. Born between 1/7/1988 and 31/12/1989
3. Living in selected Health Centre (HC) catchment area's
4. Informed consent participant and parent/guardian

Exclusion Criteria

Added as of 23/04/2007:
1. No complete informed consent
2. No match found
3. Not fully vaccinated in infancy
4. Not in age range

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Added as of 23/04/2007:<br>Anti-HBs titers after one year.
Secondary Outcome Measures
NameTimeMethod
Added as of 23/04/2007:<br>Proportion without anamnestic response following boosting.
© Copyright 2025. All Rights Reserved by MedPath